{{Rsnum
|rsid=17779457
|Gene=MOB3B
|Chromosome=9
|position=27488094
|Orientation=plus
|GMAF=0.2677
|Gene_s=MOB3B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 8.8 | 30.1 | 61.1
| HCB | 13.9 | 41.6 | 44.5
| JPT | 4.4 | 34.5 | 61.1
| YRI | 5.4 | 32.0 | 62.6
| ASW | 5.3 | 31.6 | 63.2
| CHB | 13.9 | 41.6 | 44.5
| CHD | 16.5 | 45.9 | 37.6
| GIH | 4.0 | 34.7 | 61.4
| LWK | 3.6 | 40.9 | 55.5
| MEX | 10.3 | 46.6 | 43.1
| MKK | 3.2 | 36.5 | 60.3
| TSI | 7.8 | 43.1 | 49.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23376709
  |Trait=Urinary symptoms in response to radiotherapy in prostate cancer
  |Title=A 2-Stage Genome-Wide Association Study to Identify Single Nucleotide Polymorphisms Associated with Development of Urinary Symptoms After Radiotherapy for Prostate Cancer.
  |RiskAllele=
  |Pval=7E-7
  |OR=2.40
  |ORtxt=[1.1-3.6] unit increase
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}